INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

International Clinical Psychopharmacology (ISSN 0268-1315) is a peer-reviewed, bimonthly journal published in the United Kingdom by Lippincott Williams & Wilkins, dedicated to advancing the field of clinical psychopharmacology. Indexed in the Science Citation Index (SCI), the journal maintains an impact factor typically ranging between 2 and 3, positioning it as a respected mid-tier publication within the medical and pharmacological sciences, often classified in the third or fourth quartile of the Chinese Academy of Sciences journal ranking. As a non-open access publication, it serves a global audience of psychiatrists, pharmacologists, and clinical researchers by disseminating high-quality empirical data and critical analyses on the therapeutic applications, pharmacokinetics, pharmacodynamics, and adverse effects of psychotropic agents, with a particular emphasis on antidepressants, antipsychotics, and anxiolytics. The journal accepts a diverse range of manuscript types, including original clinical trials, case reports, comprehensive reviews, and meta-analyses, all subject to rigorous editorial standards that ensure scientific integrity and clinical relevance. While its influence is solid within its specific niche, authors are advised to carefully align their research themes with the journal’s focus on practical clinical insights, as its moderate impact factor may limit its reach in highly competitive subfields compared to top-tier general medical journals.